ProstaLund Investor Relations Material
Latest events
Q4 2024
ProstaLund
Q1 2025
30 May, 2025
Q4 2024
20 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from ProstaLund
Access all reports
ProstaLund AB develops and sells urological devices for the treatment of patients with benign prostatic hyperplasia (BPH) internationally. The company offers BeeVital, a non-surgical therapy for BPH. It also provides Revive Flow, a laser treatment for neurogenic bladder; and Revive Basal, a drug for neurogenic bladder. The company distributes its products in the United States, Latin America, Canada, Europe, and Australia through specialized support centers. ProstaLund is hardquartered in Lund, Sweden.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
PLUN
Country
🇸🇪 Sweden